Showing results (31-40 of 1,434) with videos related to

Sort By:
Pageof 144
Bone Marrow Transplantation|December 1, 1996
Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in womenS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|January 10, 2002
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcomeA Safdar, F van Rhee, J P Henslee-Downey, et al.
Bone Marrow Transplantation|October 16, 2002
Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrheaM Tomblyn, L Gordon, S Singhal, et al.
Bone Marrow Transplantation|November 1, 1995
Comparison of Cobe Spectra and Haemonetics MCS-3P cell separators for peripheral blood stem cell harvestingJ Mehta, R Powles, S Cabral, et al.
Bone Marrow Transplantation|November 25, 1998
Red cell fragmentation (schistocytosis) after bone marrow transplantationA Zomas, R Saso, R Powles, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemiaP Glynne, R Powles, J Steele, et al.
Leukemia|June 1, 1997
Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftmentS Singhal, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapyJ Mehta, R Powles, J Treleaven, et al.
Journal of Clinical Apheresis|January 1, 1997
Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignanciesJ Mehta, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|June 12, 2002
Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?J Mehta, R Powles, B Sirohi, et al.
Pageof 144